Holmarc Opto-Mechatronics Ltd Management Discussions

1. INDUSTRY STRUCTURE AND DEVELOPMENTS

Global economic activity is projected to remain steady, with growth forecast at 3.0% in 2025 and 3.1% in 2026, as per the IMFs April 2025 World Economic Outlook. India is expected to maintain its position as the fastest-growing major economy, with projected GDP growth of 6.2% in 2025 and 6.3% in 2026.

The global scientificinstruments market was valued at US$ 46.2 billion in 2024, driven by continued technological advancements and the need for increasingly sophisticated and precise tools.

Rising investment in scientific research by governments, private enterprises, and academic institutions, particularly in the Asia-Pacific region—with China and India as key contributors—has accelerated demand. The sector is projected to grow at a CAGR of 4.7% by 2030.

In India, policy initiatives such as "Make in India", expansion of digital infrastructure, and improvements in logistics efficiency have strengthened the manufacturing ecosystem. Strong credit growth, robust GST collections, and a healthy manufacturing PMI reflect positive industrial momentum. Fiscal prudence and sound financial indicators continue to support a conducive business environment.

According to IMARC Group data, the Indian spectroscopy market reached US$ 544.5 million in 2024 and is projected to grow at 5.91% CAGR to US$ 914.7 million by 2033. Growth is being driven by rising adoption of advanced analytical technologies across pharmaceuticals, biotech-nology, environmental monitoring, and food safety applications. The demand for spectroscopy solutions is further fuelled by stringent quality control requirements and increasing R&D activities. The broader Indian analytical instruments market is expanding on account of technological advances, increasing focus on quality control, and a surge in research-driven applications. Analytical instruments—used to identify, quantify, and analyze materials—are now integral to sectors such as chemistry, pharmaceuticals, and environmental sciences. As per Grand View Research, the analytical instrumentation market in India — encompassing laboratory, industrial, and research-grade instruments — was valued at USD 1,857.9 million in 2024 and is projected to reach USD 3,686.9 million by 2033, registering a robust CAGR of 8.2%.

Spectroscopy, in particular, remains central to scientific investigation. It studies the interaction of electromagnetic radiation with matter to reveal material structure, composition, and properties—ranging from the study of distant galaxies to nano-scale material characterization. Coupling spectroscopy with complementary techniques such as chromatography, microscopy, and mass spectrometry is expected to deliver deeper, more comprehensive insights in both industrial and research applications.

2. SWOT ANALYSIS

STRENGTHS

1. The Company enjoys a strong market presence with a well-established brand recognized for delivering high-quality and durable products.

2. A highly experienced and technically competent workforce enables efficient operations and supports the Companys long-term strategic goals.

3. Continuous investment in research and development facilitates product innovation, customization, and differentiation in a competitive . market

WEAKNESS

1. Increasing costs of raw materials and logistics continue to exert pressure on operating margins.

2. Limited physical space poses challenges in scaling up manufacturing and warehousing capabilities efficiently.

OPPORTUNITIES

1. Increasing government initiatives and funding, particularly in life sciences and healthcare, are expected to boost demand for advanced analytical instrumentation.

2. Growing adoption of sophisticated techniques such as Raman Spectroscopy across industries enhances product relevance.

3. Analytical instruments are witnessing wider usage in areas such as food safety, environmental monitoring, and healthcare, creating new market avenues.

4. A large number of academic and research institutions provide opportunities for collaboration and instrument sales.

5. The rapid growth of the pharmaceutical and biotechnology sectors is driving demand for precision instrumentation and analytical tools.

THREATS

1. Influx of low-cost imported products and an extended global supply chain pose challenges to domestic market share and pricing strategies.

2. Potential risks associated with employee conduct and compliance may affect operations.

3. Irregular and unreliable power supply can disrupt production and research activities.

4. Outdated regulatory frameworks and inconsistent government policies can hinder innovation and slow down time-to-market.

5. Imposition of tariffs and other trade restrictions may impact import/export operations and procurement strategies.

3. OUTLOOK

The Company expects steady growth in the coming periods, supported by strategic initiatives in capacity expansion and deeper market penetration across both core and emerging segments.

During the financial year 2024 25, the Company achieved significant -enue from operations increased to 3,596.99 lakhs, reflectinga growth of 10.94% over the previous year. Notably, the Company improved its performance in the production and sale of two major product groups — Spectroscopy and Analytical Instruments.

Turnover from Spectroscopy increased by 35.52%.

Turnover from Analytical Instruments increased by 19.87%.

A significant milestone for the year

The addition of 63 new dealers across India is expected to strengthen market reach and position the Company as a prominent player in the domestic Spectroscopy and Analytical Instruments market.

4. RISK AND CONCERNS

The Companys growth prospects are influenced by a range of operational, market, and regulatory risks. Rising costs of raw materials, coupled with intense competition from low-cost imported products, create sustained pressure on pricing strategies and operating margins. This competitive cost environment necessitates continuous focus on supply chain efficiency, cost optimization, and value-added product differentiation to -ulatory environment presents additional uncertainties. Outdated frameworks, inconsistent policy directives, and shifting trade regulations may delay product launches, hinder innovation cycles, and create unpredictability in procurement and export planning. In particular, the imposition of tariffs or other trade restrictions could alter the cost structure and competitiveness of the Companys offerings in both domestic and international markets.

The Company remains committed to proactively identifying, assessing, and mitigating these risks through robust monitoring systems, operational safeguards, and strategic planning.

5. INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY

The Company has a well-structured internal audit framework designed to provide reasonable assurance on the effectiveness of accounting controls, operational efficiency, safeguarding of assets against unauthorized use or loss, and the reliability of financial and operational information. Internal audit reports are periodically reviewed by the Management, and recommended modifications or corrective actions are implemented to further strengthen systems and enhance overall performance.

6. DISCUSSION ON FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE